These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. COCONEL Group Lancet Infect Dis; 2020 Jul; 20(7):769-770. PubMed ID: 32445713 [No Abstract] [Full Text] [Related]
23. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports"). Persad G; Emanuel EJ JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357 [No Abstract] [Full Text] [Related]
24. Developing Covid-19 Vaccines at Pandemic Speed. Lurie N; Saville M; Hatchett R; Halton J N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757 [No Abstract] [Full Text] [Related]
26. Authors' reply to Kolstoe and Hanna and colleagues. van der Westhuizen HM; Kotze K; Tonkin-Crine S; Gobat N; Greenhalgh T BMJ; 2020 Oct; 371():m3799. PubMed ID: 33008828 [No Abstract] [Full Text] [Related]
27. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities. Wang EA; Zenilman J; Brinkley-Rubinstein L JAMA; 2020 Sep; 324(11):1031-1032. PubMed ID: 32808972 [No Abstract] [Full Text] [Related]
28. Genetic characterization of SARS-CoV-2 & implications for epidemiology, diagnostics & vaccines in India. Abraham P; Cherian S; Potdar V Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):12-15. PubMed ID: 32896836 [No Abstract] [Full Text] [Related]
29. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection. Simon HU; Karaulov AV; Bachmann MF Int Arch Allergy Immunol; 2020; 181(8):624-628. PubMed ID: 32544911 [TBL] [Abstract][Full Text] [Related]
31. All eyes on a hurdle race for a SARS-CoV-2 vaccine. Gaebler C; Nussenzweig MC Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943 [No Abstract] [Full Text] [Related]
33. All roads lead to coronavirus. Abbasi K J R Soc Med; 2020 Mar; 113(3):91. PubMed ID: 32160122 [No Abstract] [Full Text] [Related]
34. Even covid-19 can't kill the anti-vaccination movement. Megget K BMJ; 2020 Jun; 369():m2184. PubMed ID: 32499217 [No Abstract] [Full Text] [Related]
35. The Regulation of COVID-19 "Challenge" Studies. Menikoff J Am J Bioeth; 2020 Jul; 20(7):80-82. PubMed ID: 32716768 [No Abstract] [Full Text] [Related]
36. Ensuring global access to COVID-19 vaccines. Yamey G; Schäferhoff M; Hatchett R; Pate M; Zhao F; McDade KK Lancet; 2020 May; 395(10234):1405-1406. PubMed ID: 32243778 [No Abstract] [Full Text] [Related]
37. Understanding COVID-19 Vaccines and Their Development. Patel SS; Kalma J; Bluman EM J Bone Joint Surg Am; 2020 Oct; 102(20):1759-1769. PubMed ID: 33086342 [No Abstract] [Full Text] [Related]
38. [COVID-19 coronavirus: what implications for Cardiology?]. Di Pasquale G G Ital Cardiol (Rome); 2020 Apr; 21(4):243-245. PubMed ID: 32202553 [No Abstract] [Full Text] [Related]
39. Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial. Usmani SS; Raghava GPS Front Immunol; 2020; 11():561851. PubMed ID: 33133071 [No Abstract] [Full Text] [Related]
40. COVID-19 vaccines: time to talk about the uncertainties. Subbarao K Nature; 2020 Oct; 586(7830):475. PubMed ID: 33082537 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]